A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
Public ClinicalTrials.gov record NCT00797108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-blind, Double-dummy Efficacy, Safety And Tolerability Study Of Iv Sulopenem With Switch To Oral Pf-03709270 Compared To Ceftriaxone With Step Down To Amoxicillin/Clavulanate Potassium (Augmentin) In Subjects With Community Acquired Pneumonia (Cap) Requiring Hospitalization
Study identification
- NCT ID
- NCT00797108
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Interventions
- Sulopenem and PF-03709270 Drug
- Ceftriaxone and amoxicillin/clavulanate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- May 31, 2009
- Completion
- May 31, 2009
- Last update posted
- Mar 9, 2016
2009
United States locations
- U.S. sites
- 12
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| eStudySite, Inc. | Chula Vista | California | 91911 | — |
| Sharp Chula Vista Medical Center | Chula Vista | California | 91911 | — |
| eStudySite, Inc. | Oceanside | California | 92056 | — |
| Tri-City Medical Center | Oceanside | California | 92056 | — |
| Medical Arts Associates, Ltd | Moline | Illinois | 61265 | — |
| Trinity Medical Center | Rock Island | Illinois | 61201 | — |
| Infectious Disease Minneapolis Limited | Minneapolis | Minnesota | 55422 | — |
| Summa Health System | Akron | Ohio | 44304 | — |
| Summa Health System | Akron | Ohio | 44309 | — |
| Summa Health System | Akron | Ohio | 44310 | — |
| Utah Valley Pulmonary Clinic | Provo | Utah | 84604 | — |
| Utah Valley Regional Medical Center | Provo | Utah | 84604 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00797108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2016 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00797108 live on ClinicalTrials.gov.